Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Trial of Fluticasone in Bronchial Premalignancy
This study has been completed.
Study NCT00407264   Information provided by VU University Medical Center
First Received: November 28, 2006   Last Updated: November 29, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bronchogenic Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Bronchogenic
More general conditions related to this trial
Lung Diseases
Lung Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
Fluticasone propionate
Additional drug interventions recognized in this trial
Fluticasone
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Dermatologic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
VU University Medical Center
GlaxoSmithKline
The Netherlands Cancer Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services